Search Results - "Fishbein, Daniel P."

Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT by Poole, Jeanne E., Olshansky, Brian, Mark, Daniel B., Anderson, Jill, Johnson, George, Hellkamp, Anne S., Davidson-Ray, Linda, Fishbein, Daniel P., Boineau, Robin E., Anstrom, Kevin J., Reinhall, Per G., Packer, Douglas L., Lee, Kerry L., Bardy, Gust H.

“…The SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) randomized 2,521 patients with moderate heart failure (HF) to amiodarone, placebo drug, or…”
Get full text

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure by Bardy, Gust H, Lee, Kerry L, Mark, Daniel B, Poole, Jeanne E, Packer, Douglas L, Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E, Clapp-Channing, Nancy, Davidson-Ray, Linda D, Fraulo, Elizabeth S, Fishbein, Daniel P, Luceri, Richard M, Ip, John H

“…This placebo-controlled study compared the effect of amiodarone and an implantable cardioverter–defibrillator (ICD) on mortality in patients with New York…”
Get full text

Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high‐risk donor seropositive/recipient seronegative heart transplant recipients by Imlay, Hannah, Dumitriu Carcoana, Allison O., Fisher, Cynthia E., Wong, Beatrice, Rakita, Robert M., Fishbein, Daniel P., Limaye, Ajit P.

“…Background Few data support use of 6 over 3 months of antiviral prophylaxis for cytomegalovirus (CMV) disease prevention in donor seropositive/recipient…”
Get full text

Systematic donor selection review process improves cardiac transplant volumes and outcomes by Smith, Jason W., MD, O'Brien, Kevin D., MD, Dardas, Todd, MD, Pal, Jay D., MD, PhD, Fishbein, Daniel P., MD, Levy, Wayne C., MD, Mahr, Claudius, DO, Masri, Sofia C., MD, Cheng, Richard K., MD, Stempien-Otero, April, MD, Mokadam, Nahush A., MD

“…Abstract Background Heart transplant remains the definitive therapy for advanced heart failure patients but is limited by organ availability. We identified a…”
Get full text

Incidence and Clinical Features of Ganciclovir- Resistant Cytomegalovirus Disease in Heart Transplant Recipients by Li, Fanny, Kenyon, Kenneth W., Kirby, Katharine A., Fishbein, Daniel P., Boeckh, Michael, Limaye, Ajit P.

“…Background.The incidence and clinical and virologic aspects of ganciclovir-resistant cytomegalovirus (CMV) disease have not been well-characterized in heart…”
Get full text

Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement by Ketchum, Eric S., MD, Moorman, Alec J., MD, Fishbein, Daniel P., MD, Mokadam, Nahush A., MD, Verrier, Edward D., MD, Aldea, Gabriel S., MD, Andrus, Shauna, BSN, RN, Kenyon, Kenneth W., PharmD, Levy, Wayne C., MD

“…Background Left ventricular assist devices (LVADs) are increasingly used in advanced heart failure patients. Despite proven efficacy, optimal timing of LVAD…”
Get full text

Use of the 6-Min Walk Distance to Identify Variations in Treatment Benefits From Implantable Cardioverter-Defibrillator and Amiodarone by Fishbein, Daniel P., MD, Hellkamp, Anne S., MS, Mark, Daniel B., MD, MPH, Walsh, Mary Norine, MD, Poole, Jeanne E., MD, Anderson, Jill, BSN, RN, Johnson, George, BSEE, Lee, Kerry L., PhD, Bardy, Gust H., MD

“…Objectives The purpose of this study was to determine if 6-min walk test data assists in treatment decisions for patients with heart failure. Background In the…”
Get full text

Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure by Poole, Jeanne E, Johnson, George W, Hellkamp, Anne S, Anderson, Jill, Callans, David J, Raitt, Merritt H, Reddy, Ramakota K, Marchlinski, Francis E, Yee, Raymond, Guarnieri, Thomas, Talajic, Mario, Wilber, David J, Fishbein, Daniel P, Packer, Douglas L, Mark, Daniel B, Lee, Kerry L, Bardy, Gust H

“…In the Sudden Cardiac Death in Heart Failure Trial, 811 patients were randomly assigned to receive implantable cardioverter–defibrillators (ICDs). Of these…”
Get full text

Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy by Huggins, Gordon S, Kinnamon, Daniel D, Haas, Garrie J, Jordan, Elizabeth, Hofmeyer, Mark, Kransdorf, Evan, Ewald, Gregory A, Morris, Alanna A, Owens, Anjali, Lowes, Brian, Stoller, Douglas, Tang, W. H. Wilson, Garg, Sonia, Trachtenberg, Barry H, Shah, Palak, Pamboukian, Salpy V, Sweitzer, Nancy K, Wheeler, Matthew T, Wilcox, Jane E, Katz, Stuart, Pan, Stephen, Jimenez, Javier, Aaronson, Keith D, Fishbein, Daniel P, Smart, Frank, Wang, Jessica, Gottlieb, Stephen S, Judge, Daniel P, Moore, Charles K, Mead, Jonathan O, Ni, Hanyu, Burke, Wylie, Hershberger, Ray E

“…IMPORTANCE: Idiopathic dilated cardiomyopathy (DCM) aggregates in families, and early detection in at-risk family members can provide opportunity to initiate…”
Get full text

Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives by Ni, Hanyu, Jordan, Elizabeth, Kinnamon, Daniel D., Cao, Jinwen, Haas, Garrie J., Hofmeyer, Mark, Kransdorf, Evan, Ewald, Gregory A., Morris, Alanna A., Owens, Anjali, Lowes, Brian, Stoller, Douglas, Tang, W.H. Wilson, Garg, Sonia, Trachtenberg, Barry H., Shah, Palak, Pamboukian, Salpy V., Sweitzer, Nancy K., Wheeler, Matthew T., Wilcox, Jane E., Katz, Stuart, Pan, Stephen, Jimenez, Javier, Fishbein, Daniel P., Smart, Frank, Wang, Jessica, Gottlieb, Stephen S., Judge, Daniel P., Moore, Charles K., Huggins, Gordon S., Hershberger, Ray E.

“…Cardiovascular screening is recommended for first-degree relatives (FDRs) of patients with dilated cardiomyopathy (DCM), but the yield of FDR screening is…”
Get full text

Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population by LEVY, Wayne C, LEE, Kerry L, JOHNSON, George, ANDERSON, Jill, MARK, Daniel B, BARDY, Gust H, HELLKAMP, Anne S, POOLE, Jeanne E, MOZAFFARIAN, Dariush, LINKER, David T, MAGGIONI, Aldo P, ANAND, Inder, POOLE-WILSON, Philip A, FISHBEIN, Daniel P

“…Although implantable cardioverter-defibrillator (ICD) therapy reduces mortality in moderately symptomatic heart failure patients with an ejection fraction…”
Get full text

Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry by Jordan, Elizabeth, Kinnamon, Daniel D, Haas, Garrie J, Hofmeyer, Mark, Kransdorf, Evan, Ewald, Gregory A, Morris, Alanna A, Owens, Anjali, Lowes, Brian, Stoller, Douglas, Tang, W. H. Wilson, Garg, Sonia, Trachtenberg, Barry H, Shah, Palak, Pamboukian, Salpy V, Sweitzer, Nancy K, Wheeler, Matthew T, Wilcox, Jane E, Katz, Stuart, Pan, Stephen, Jimenez, Javier, Fishbein, Daniel P, Smart, Frank, Wang, Jessica, Gottlieb, Stephen S, Judge, Daniel P, Moore, Charles K, Mead, Jonathan O, Hurst, Natalie, Cao, Jinwen, Huggins, Gordon S, Cowan, Jason, Ni, Hanyu, Rehm, Heidi L, Jarvik, Gail P, Vatta, Matteo, Burke, Wylie, Hershberger, Ray E

“…IMPORTANCE: Black patients with dilated cardiomyopathy (DCM) have increased familial risk and worse outcomes than White patients, but most DCM genetic data are…”
Get full text

Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial by Kinnamon, Daniel D., Jordan, Elizabeth, Haas, Garrie J., Hofmeyer, Mark, Kransdorf, Evan, Ewald, Gregory A., Morris, Alanna A., Owens, Anjali, Lowes, Brian, Stoller, Douglas, Tang, W.H. Wilson, Garg, Sonia, Trachtenberg, Barry H., Shah, Palak, Pamboukian, Salpy V., Sweitzer, Nancy K., Wheeler, Matthew T., Wilcox, Jane E., Katz, Stuart, Pan, Stephen, Jimenez, Javier, Aaronson, Keith D., Fishbein, Daniel P., Smart, Frank, Wang, Jessica, Gottlieb, Stephen S., Judge, Daniel P., Moore, Charles K., Mead, Jonathan O., Huggins, Gordon S., Ni, Hanyu, Burke, Wylie, Hershberger, Ray E.

“…Managing disease risk among first-degree relatives of probands diagnosed with a heritable disease is central to precision medicine. A critical component is…”
Get full text

Right ventricular sarcoidosis: is it time for updated diagnostic criteria? by Vakil, Kairav, Minami, Elina, Fishbein, Daniel P

“…A 55-year-old woman with a history of complete heart block, atrial flutter, and progressive right ventricular failure was referred to our tertiary care center…”
Get full text

Examining valganciclovir prophylaxis duration among high‐risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort by Imlay, Hannah, Dumitriu Carcoana, Allison O., Fisher, Cynthia E., Wong, Beatrice, Rakita, Robert M., Fishbein, Daniel P., Limaye, Ajit P.

Get full text

TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study by Trachtenberg, Barry H., Jimenez, Javier, Morris, Alanna A., Kransdorf, Evan, Owens, Anjali, Fishbein, Daniel P., Jordan, Elizabeth, Kinnamon, Daniel D., Mead, Jonathan O., Huggins, Gordon S., Hershberger, Ray E., Hershberger, Ray E., Kinnamon, Daniel D., Jordan, Elizabeth, Haas, Garrie, Huggins, Gordon S., Fishbein, Daniel, Gottlieb, Stephen S., Wheeler, Matthew T., Hofmeyer, Mark, Tang, W. H. Wilson, Owens, Anjali T., Moore, Charles K., Carcamo, Javier Jimenez, Trachtenberg, Barry, Sweitzer, Nancy K., Shah, Palak, Lowes, Brian, Stoller, Douglas, Smart, Frank, Morris, Alanna A., Wilcox, Jane, Katz, Stuart, Ewald, Gregory A., Aaronson, Keith D., Wang, Jessica J., Pamboukian, Salpy, Judge, Daniel P., Kransdorf, Evan P., Garg, Sonia, Desvigne-Nickens, Patrice, Troendle, James, Fu, Yi-Ping, Hindorff, Lucia

“…The cardiac phenotype of hereditary transthyretin amyloidosis (hTTR) usually presents as a restrictive or hypertrophic cardiomyopathy, and, although rarely…”
Get full text

Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure by Packer, Milton, Abraham, William T., Mehra, Mandeep R., Yancy, Clyde W., Lawless, Christine E., Mitchell, Judith E., Smart, Frank W., Bijou, Rachel, O’Connor, Christopher M., Massie, Barry M., Pina, Ileana L., Greenberg, Barry H., Young, James B., Fishbein, Daniel P., Hauptman, Paul J., Bourge, Robert C., Strobeck, John E., Murali, Srinvivas, Schocken, Douglas, Teerlink, John R., Levy, Wayne C., Trupp, Robin J., Silver, Marc A.

“…Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure Milton…”
Get full text

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) by Fishbein, Daniel P, Hellkamp, Anne S, Mark, Daniel B, Walsh, Mary Norine, Poole, Jeanne E, Anderson, Jill, Johnson, George, Lee, Kerry L, Bardy, Gust H

“…The purpose of this study was to determine if 6-min walk test data assists in treatment decisions for patients with heart failure. In the SCD-HeFT (Sudden…”
Get full text

Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates by Levy, Wayne C., Hellkamp, Anne S., Mark, Daniel B., Poole, Jeanne E., Shadman, Ramin, Dardas, Todd F., Anderson, Jill, Johnson, George, Fishbein, Daniel P., Lee, Kerry L., Linker, David T., Bardy, Gust H.

“…The authors previously developed the Seattle Proportional Risk Model (SPRM) in systolic heart failure patients without implantable cardioverter-defibrillators…”
Get full text

Usefulness of Relative Lymphocyte Count as an Independent Predictor of Death/Urgent Transplant in Heart Failure by Huehnergarth, Kier V., Mozaffarian, Dariush, Sullivan, Mark D., Crane, Barbara A., Wilkinson, Charles W., Lawler, Richard L., McDonald, George B., Fishbein, Daniel P., Levy, Wayne C.

“…The usefulness of low relative lymphocyte count as an independent predictor of death/urgent transplant in patients with heart failure (HF) and the association…”
Get full text